| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |